The outdated statistic quoted by commentators is that 16% of the population are covered by medical schemes, and therefore 84% are dependent on the state
Rhulani Nhlaniki is Pfizer’s cluster lead for sub-Saharan Africa. As Pfizer starts phase III of the clinical trial of their Covid-19 vaccine candidate, he tells Malaikah Bophela that if it is successful, the company will ensure the vaccine will be available to everyone who needs it